SCHEMBL10770970

SCHEMBL10770970

c1cc(OCC2CO2)c2nnn(C3CCCCO3)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ GRM2 Q14416 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ PDE8B O95263 4/20 0.35
▸ HRH3 Q9Y5N1 2/20 0.34
▸ CYP4F2 P78329 4/20 0.34
▸ CYP4A11 Q02928 4/20 0.34
▸ MCHR1 Q99705 3/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ PDE5A O76074 1/20 0.32
▸ PDE1A P54750 1/20 0.32
▸ PDE1B Q01064 1/20 0.32
▸ PDE1C Q14123 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10775607 1.00 ALDH1A1 (0.39) ALDH1A1GLAGRM2SMN1; SMN2TP53
SCHEMBL10775612 1.00 ALDH1A1 (0.39) ALDH1A1GLAGRM2SMN1; SMN2TP53
SCHEMBL10770777 1.00 ALDH1A1 (0.39) ALDH1A1GLAGRM2SMN1; SMN2TP53
SCHEMBL10770782 1.00 ALDH1A1 (0.39) ALDH1A1GLAGRM2SMN1; SMN2TP53
SCHEMBL7272765 0.80 RXRA (0.39) ALDH1A1GLASMN1; SMN2TP53CYP3A4
SCHEMBL10770956 0.76 CYP4F2 (0.38) ALDH1A1GRM2TP53PDE8BCYP4F2
SCHEMBL31178734 0.73 ATR (0.39) ALDH1A1PDE8BCYP4F2CYP4A11
SCHEMBL806435 0.70 USP2 (0.49) ALDH1A1GLACYP3A4TSHRNPC1
SCHEMBL31586146 0.69 PDE8B (0.40) ALDH1A1PDE8BCYP4F2CYP4A11
SCHEMBL21550760 0.69 CYP4F2 (0.39) ALDH1A1PDE8BCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0231444-A2 Optically active isomers and racemate of 1-(benztriazol-4-yloxy)-3-[2-(2-methoxyphenoxy)-ethylamino]-2-propanol, process for their preparation as well as their use as medicaments Roche Diagnostics GmbH (DE) 1987-08-12 — — EP claimed
EP-0231444-A2 Optically active isomers and racemate of 1-(benztriazol-4-yloxy)-3-[2-(2-methoxyphenoxy)-ethylamino]-2-propanol, process for their preparation as well as their use as medicaments Roche Diagnostics GmbH (DE) 1987-08-12 — — EP disclosed
Send feedback